Parasitology Market Analysis and Reports | France Conference Series

Market Analysis - Parasitology 2018

Importance & Scope:

Performs basic research here parasite of humans and animals at the level of molecules, cells and whole organisms. The mission is to acquire, enhance and distribute knowledge about the biology and ecology of parasitic protozoa and eukaryotic microorganisms, helminths and arthropods. The Institutes in Paris carries out not only research but also education on a national and international level. The main research areas encompass parasitology, helminthology, and medical entomology, including studies on the causative agents of the infections transmitted by arthropods.

Conference Highlights:

Basic Parasitology

Parasitic Hosts

Therapeutic Parasitology

Protozoology

Helminthology

Experimental Parasitology

Arthropod Parasites

Anatomical Parasitology

Veterinary Parasitology

Transmission of Parasitic Infection

Immunoparasitology

Tested Parasitology

Equatorial Parasitology

Cataloging of Parasites

Benefits of Parasites

Epidemiology of Bacterial Infections

Analysis and Limitation of Parasitic Diseases

Vector-borne Diseases

Molecular Biology and Immune Evasion

Marine Parasites and Exposure to Public Health

Parasitic infections affect millions of people every year:

More than 300,000 persons living are infected with Trypanosoma cruzi, the cause of Chagas disease.

At least 1,000 people are hospitalized with neurocysticercosis every year.

Each year at least 70 people, most of them children, are blinded by the parasite that causes Toxocariasis.

More than 60 million persons are chronically infected with Toxoplasma gondii.

Each year 1.1 million people are newly infected with Trichomonas.

WHO estimates that about 655,000 people die from malaria every year, though a recent systematic analysis suggested the true annual mortality is closer to 1.24 million (Murray et al., 2012). Inexpensive oral drugs—chloroquine and sulfadoxine-pyrimethamine—were once common treatment for malaria, but resistance to these treatments is widespread (WHO, 2012c). Since 2001, the WHO has recommended treating malaria with artemisinin combination therapies (WWARN, 2012c). The use of artemisinin combination drugs as first-line therapy is essential to malaria control. As of 2006, however, there is evidence of artemisinin resistance in Southeast Asia (WWARN, 2012c).

Value for Antimalarial Drugs

Two hundred and eighteen antimalarial drugs were in circulation in Kenya in 2002. These included 65 "sulfur"-pyrimethamine (sulfadoxine-pyrimethamine and sulfalene-pyrimethamine (SP), the first-line recommended drug in 2002) and 33 amodiaquine (AQ, the second-line recommended drug) preparations. Only half of SP and AQ products were registered with the Pharmacy and Poisons Board. Of SP and AQ brands at district level, 40% and 44% were officially within legal registration requirements. 29% of retailers at district level stocked SP and 95% stocked AQ. The retail price of adult doses of SP and AQ were on average 0.38 and 0.76 US dollars, 100% and 347% higher than trade prices from manufacturers and importers. Artemether-lumefantrine, the newly announced first-line recommended antimalarial drug in 2004, was found in less than 1% of all retail outlets at a median cost of 7.6 US dollars.

 

 

Conferenceseries invites all the participants from all over the world to attend '5th International Conference on Parasitology' during July 12-13, 2018 in Paris, France which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Parasitology-2018 is to gathering people in academia and society interested in parasitology to share the latest trends and important issues relevant to our field/subject area. The scientific programme of the conference is broad and embraces different research aspects with focus on applied and ecological parasitology, and in particular with a veterinary and medical interest. The conference will include invited speakers, oral presentations, poster session and the young scientist award. Conferenceseries organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publish 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Why to attend??

With members from around the world focused on learning about parasitology and its advances; this is your best opportunity to reach the largest assemblage of participants from the parasitology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Parasitology are hallmarks of this conference.

Target Audience

Parasitology Students, Scientists

Parasitology Researchers

Parasitology Faculty

Medical Colleges

Parasitology Associations and Societies

Business Entrepreneurs

Training Institutes

Manufacturing Medical Devices Companies

Scientific Sessions

Conferenceseries LLC invites all the participants from all over the world to attend '5th International Conference on Parasitology' during July 12-13, 2018 in Paris, France which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Parasitology-2018 is to gathering people in academia and society interested in parasitology to share the latest trends and important issues relevant to our field/subject area. The scientific program of the conference is broad and embraces different research aspects with focus on applied and ecological Parasitology, and in particular with a veterinary nd medical interest. The conference will include invited speakers, oral presentations, poster session and the young scientist award.